prednisone has been researched along with Hyperpigmentation in 10 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 7.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
| "We describe a 55-year-old woman suffering from Sezary syndrome, had undergone chemotherapy consisting of cycles of cyclophosphamide and prednisone." | 3.79 | Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation. ( Aouem, K; Belhadjali, H; Laatiri, A; Mokni, S; Moussa, A; Youssef, M; Zili, J, 2013) |
| "We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 3.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández-Aragüés, I | 1 |
| Baniandrés-Rodríguez, O | 1 |
| Vilas-Boas, PT | 1 |
| Conde-Montero, E | 1 |
| Suárez-Fernández, R | 1 |
| Salgado, F | 1 |
| Connett, J | 1 |
| Kirkpatrick, C | 1 |
| Marchell, R | 1 |
| Youssef, M | 1 |
| Mokni, S | 1 |
| Belhadjali, H | 1 |
| Aouem, K | 1 |
| Moussa, A | 1 |
| Laatiri, A | 1 |
| Zili, J | 1 |
| Almodovar-Real, A | 1 |
| López-Delgado, D | 1 |
| Diaz-Martinez, MA | 1 |
| Fernández-Pugnaire, MA | 1 |
| Puri, PK | 1 |
| Lountzis, NI | 1 |
| Tyler, W | 1 |
| Ferringer, T | 1 |
| Zhao, X | 1 |
| Shi, R | 1 |
| Jin, X | 1 |
| Zheng, J | 1 |
| Briani, C | 1 |
| Scarlato, M | 1 |
| Pavan, A | 1 |
| Marcolongo, R | 1 |
| Rondinone, R | 1 |
| Adami, F | 1 |
| Kurzen, C | 1 |
| Kunz, I | 1 |
| Nigg, C | 1 |
| Sampson, JE | 1 |
| Harmon, ML | 1 |
| Cushman, M | 1 |
| Krawitt, EL | 1 |
| Schulte-Huermann, P | 1 |
| Zumdick, M | 1 |
| Ruzicka, T | 1 |
10 other studies available for prednisone and Hyperpigmentation
| Article | Year |
|---|---|
Cutaneous drug Reactions: Chemotherapy-induced hyperpigmentation.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2017 |
Lesions with a distinct black pigment.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Arm; Dermatitis, Toxicodendron; Diagnosi | 2018 |
Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Hyper | 2013 |
[Widespread pigmentation following long-term minocycline therapy].
Topics: Arthritis, Infectious; Arthritis, Rheumatoid; Denosumab; Drug Therapy, Combination; Female; Humans; | 2016 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2008 |
Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.
Topics: Adult; Biopsy, Needle; Castleman Disease; Diagnosis, Differential; Drug Therapy, Combination; Female | 2011 |
Polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes: not always a POEMS syndrome.
Topics: Cyclosporine; Diagnostic Errors; Eosinophilia; Fasciitis; Hepatomegaly; Humans; Hyperpigmentation; I | 2006 |
[Blue discoloration of hands, numbness of feet, indolent cervical lymph node swelling in a 73-year-old man].
Topics: Aged; Castleman Disease; Diagnosis, Differential; Drug Administration Schedule; Foot; Hand Dermatose | 2006 |
Corticosteroid-responsive Cronkhite-Canada syndrome complicated by thrombosis.
Topics: Alopecia; Anticoagulants; Glucocorticoids; Humans; Hyperpigmentation; Intestinal Polyposis; Intestin | 2007 |
Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Cyclophosphamide; Doxorubicin; Fore | 1995 |